UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer

PloS one, 2022-06, Vol.17 (6), p.e0269115-e0269115

2022

Volltextzugriff (PDF)

Current status and perspectives of immune checkpoint inhibitors for colorectal cancer

Japanese journal of clinical oncology, 2021-01, Vol.51 (1), p.10-19

2021

Volltextzugriff (PDF)

Histopathological atlas of desmoplastic reaction characterization in colorectal cancer

Japanese journal of clinical oncology, 2021-06, Vol.51 (6), p.1004-1012

2021

Volltextzugriff (PDF)

Current Targeted Therapy for Metastatic Colorectal Cancer

International journal of molecular sciences, 2023-01, Vol.24 (2), p.1702

2023

Volltextzugriff (PDF)

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

BMC cancer, 2019-10, Vol.19 (1), p.974-974, Article 974

2019

Volltextzugriff (PDF)

A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2021-03, Vol.24 (2), p.479-491

2021

Volltextzugriff (PDF)

Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world

Japanese journal of clinical oncology, 2017-07, Vol.47 (7), p.583-589

2017

Volltextzugriff (PDF)

Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis

Cancer chemotherapy and pharmacology, 2018-06, Vol.81 (6), p.981-989

2018

Volltextzugriff (PDF)

Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study

Annals of surgical oncology, 2019-05, Vol.26 (5), p.1358-1365

2019

Volltextzugriff (PDF)

Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer

BMC cancer, 2020-11, Vol.20 (1), p.1092-1092, Article 1092

2020

Volltextzugriff (PDF)

Primary Tumor Resection for Stage IV Colorectal Cancer in the Era of Targeted Chemotherapy

Journal of gastrointestinal surgery, 2019-11, Vol.23 (11), p.2144-2150

2019

Volltextzugriff (PDF)

Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab

Japanese journal of clinical oncology, 2020-02, Vol.50 (2), p.114-121

2020

Volltextzugriff (PDF)

Randomized phase II study of gemcitabine plus S‐1 versus S‐1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)

Cancer science, 2013-09, Vol.104 (9), p.1211-1216

2013

Volltextzugriff (PDF)

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms

Cancers, 2022-02, Vol.14 (5), p.1119

2022

Volltextzugriff (PDF)

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2017-07, Vol.20 (4), p.655-662

2017

Volltextzugriff (PDF)

Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer

British journal of cancer, 2022-10, Vol.127 (6), p.1043-1050

2022

Volltextzugriff (PDF)

Prognostic factors of brain metastases from colorectal cancer

BMC cancer, 2019-07, Vol.19 (1), p.755-755, Article 755

2019

Volltextzugriff (PDF)

Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2023-03, Vol.26 (2), p.307-316

2023

Volltextzugriff (PDF)

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Journal of cancer research and clinical oncology, 2016-08, Vol.142 (8), p.1727-1738

2016

Volltextzugriff (PDF)

Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis

Annals of surgical oncology, 2016-10, Vol.23 (11), p.3602-3608

2016

Volltextzugriff (PDF)

Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis

Investigational new drugs, 2020-04, Vol.38 (2), p.533-540

2020

Volltextzugriff (PDF)

Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2019-07, Vol.22 (4), p.778-784

2019

Volltextzugriff (PDF)

Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer

Cancer science, 2021-04, Vol.112 (4), p.1567-1578

2021

Volltextzugriff (PDF)

Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts

Scientific reports, 2023-03, Vol.13 (1), p.3587-3587, Article 3587

2023

Volltextzugriff (PDF)

Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer

International journal of clinical oncology, 2020-06, Vol.25 (6), p.1098-1104

2020

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(287)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(169)
Life Sciences & Biomedicine
(157)
Oncology
(130)
Humans
(121)
Male
(92)
Aged
(89)
Female
(89)
Middle Aged
(83)
Chemotherapy
(78)
Adult
(71)
Medicine
(59)
Medicine & Public Health
(58)
Colorectal Cancer
(56)
Patients
(52)
Metastasis
(49)
Cancer Research
(45)
Gastric Cancer
(44)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(43)
Original Article
(40)
Prognosis
(40)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Influence of precedent drug on the subsequent therapy in the sequence of trifluridine/tipiracil with/out bevacizumab and regorafenib for unresectable or recurrent colorectal cancer

Current status and perspectives of immune checkpoint inhibitors for colorectal cancer

Histopathological atlas of desmoplastic reaction characterization in colorectal cancer

Current Targeted Therapy for Metastatic Colorectal Cancer

Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab

A nonrandomized, single-arm confirmatory trial of expanded endoscopic submucosal dissection indication for undifferentiated early gastric cancer: Japan Clinical Oncology Group study (JCOG1009/1010)

Survival after failure of first-line chemotherapy in advanced gastric cancer patients: differences between Japan and the rest of the world

Survival impact of post-progression chemotherapy in advanced gastric cancer: systematic review and meta-analysis

Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study

Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer

Primary Tumor Resection for Stage IV Colorectal Cancer in the Era of Targeted Chemotherapy

Identification of serum microRNAs predicting the response of esophageal squamous-cell carcinoma to nivolumab

Randomized phase II study of gemcitabine plus S‐1 versus S‐1 in advanced biliary tract cancer: A Japan Clinical Oncology Group trial (JCOG 0805)

Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine Neoplasms

Irinotecan monotherapy as third-line treatment for advanced gastric cancer refractory to fluoropyrimidines, platinum, and taxanes

Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer

Prognostic factors of brain metastases from colorectal cancer

Evaluating the efficacy of post-operative chemotherapy after curative resection of stage IV gastric cancer with synchronous oligo metastasis: a multicenter retrospective study

Serum levels of soluble programmed cell death ligand 1 as a prognostic factor on the first-line treatment of metastatic or recurrent gastric cancer

Prognostic Impact of Palliative Primary Tumor Resection for Unresectable Stage 4 Colorectal Cancer: Using a Propensity Score Analysis

Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis

Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer

Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin‐based or irinotecan‐based therapy for colorectal cancer

Comparison of clinicopathological and genomic profiles in anal squamous cell carcinoma between Japanese and Caucasian cohorts

Comparison of involved field radiotherapy and elective nodal irradiation in combination with concurrent chemotherapy for T1bN0M0 esophageal cancer

Suchergebnisse filtern